Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities
- 1 February 2003
- journal article
- review article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 56 (2), 96-102
- https://doi.org/10.1136/jcp.56.2.96
Abstract
The identification of the non-random chromosome rearrangements between the EWS gene on chromosome 22q12 and members of the ETS gene family in Ewing’s sarcoma, peripheral primitive neuroectodermal tumour, Askin tumour, and neuroepithelioma has been a key advance in understanding their common histogenesis and defining the Ewing’s sarcoma family of tumours (ESFT). In addition to improvements in diagnosis and potentially the stratification of patients for risk, biological investigations of these gene fusions may define targets for much needed therapeutic strategies to eliminate minimal residual disease or metastatic disease. Insight into their relation with other oncogenic events in ESFT will advance risk group analysis and ultimately may improve clinical management and survival for patients with this disease.Keywords
This publication has 92 references indexed in Scilit:
- Prognostic impact of P53 status in Ewing sarcoma.2000
- Incidence and survival for cancer in children and young adults in the North of England, 1968–1995: a report from the Northern Region Young Persons’ Malignant Disease RegistryBritish Journal of Cancer, 2000
- An Engineered PAX3-KRAB Transcriptional Repressor Inhibits the Malignant Phenotype of Alveolar Rhabdomyosarcoma Cells Harboring the Endogenous PAX3-FKHR OncogeneMolecular and Cellular Biology, 2000
- TLS-ERG Leukemia Fusion Protein Inhibits RNA Splicing Mediated by Serine-Arginine ProteinsMolecular and Cellular Biology, 2000
- Targeting Tumor Specific Translocations in Sarcomas in Pediatric Patients for ImmunotherapyPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.2000
- Association of EWS-FLI1 Type 1 Fusion with Lower Proliferative Rate in Ewing's SarcomaThe American Journal of Pathology, 2000
- Preferential down-regulation of phospholipase C- β in Ewing's sarcoma cells transfected with antisense EWS-Fli-1British Journal of Cancer, 2000
- Tumor Cell Viability in Clear Cell Sarcoma Requires DNA Binding Activity of the EWS/ATF1 Fusion ProteinPublished by Elsevier BV ,1999
- EWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's SarcomaJournal of Clinical Oncology, 1999